Kalytera expands CBD study sites

2018-09-20 08:06 ET - News Release



Mr. Robert Farrell reports
KALYTERA THERAPEUTICS PROVIDES UPDATE FOR LEAD PROGRAM IN PREVENTION AND TREATMENT OF GVHD
Kalytera Therapeutics Inc. has provided an update on its lead product development program evaluating cannabidiol (CBD) for the prevention and treatment of acute graft versus host disease (GVHD).


GVHD is a life-threatening complication commonly occurring after bone marrow transplant procedures. GVHD occurs when the transplanted donor cells attack the patient's organs, including the skin, GI tract, liver, lungs and eyes. GVHD is associated with acute and chronic illness, infections, disability, reduced quality of life, and death.

It is estimated that up to 50 per cent of patients who undergo a bone marrow transplant from a sibling donor, and up to 70 per cent of patients who undergo a bone marrow transplant from an unrelated donor, will develop some level of GVHD. There are currently no Food and Drug Administration-approved therapies for either the prevention or treatment of acute GVHD.
CBD is a non-psychotropic ingredient of cannabis that does not cause euphoria or cognitive effects. The formulation of CBD that Kalytera is evaluating for the prevention and treatment of acute GVHD is a proprietary formulation that is designed to improve product stability and absorption after oral dosing.

Kalytera's two separate programs in GVHD
The work that Kalytera is doing in GVHD consists of two separate product development programs: a program evaluating CBD for the prevention of acute GVHD; and a separate program evaluating CBD for the treatment of acute GVHD. Although there is some overlap between the two programs in terms of the data that will be required for FDA registration and marketing approval, the phase 2 and phase 3 clinical studies for each of these two programs will be separate and distinct.

The company's program in prevention of acute GVHD is more advanced than is the program in treatment of acute GVHD. The prevention program is currently in phase 2 clinical testing, with a continuing study enrolling patients at three clinical sites in Israel. To expedite the enrolment process, Kalytera is expanding this study to include one additional site in Israel and up to four additional sites in other jurisdictions, including Australia. Upon completion of this phase 2 clinical study, the company will begin preparations for the pivotal phase 3 clinical study that will be required for approval.

"We believe the best strategy for building shareholder value will be to advance our programs in GVHD to phase 3 status. We will be able to initiate the phase 3 pivotal registration study in prevention of acute GVHD ahead of the phase 3 study in treatment of acute GVHD, and for this reason, we will prioritize the program in prevention of acute GVHD over the companion program in treatment of acute GVHD," said Robert Farrell, president and chief executive officer of Kalytera. "We expect to initiate the phase 3 clinical study in prevention of acute GVHD within the next 12 months. Our plans for this program are as follows: (1) we plan to announce interim data from the ongoing phase 2 study later this year; (2) we will complete the phase 2 study in Q2 2019; and (3) we plan to initiate the phase 3 clinical study during Q3 2019. We have also begun the process of seeking corporate partnering opportunities for both of our GVHD programs. The objective of such a partnership will be to provide a non-dilutive source of funding for the programs, as well as future revenue through licensing fees, milestone payments and royalties."

Prior to the continuing phase 2 clinical study in prevention of acute GVHD, two phase 2a clinical studies were completed evaluating CBD in the prevention of GVHD. Data from both of these clinical studies were positive and highly encouraging. Dr. Moshe Yeshurun, Kalytera's chief medical officer, was the principal investigator for both of these studies, which were conducted at the Institute of Hematology, Davidoff Centre, Rabin Medical Centre, Petah Tikva, Israel. These studies were carried out by Dr. Yeshurun prior to the date he joined the company, and the company subsequently acquired the relevant technology through its acquisition of Talent Biotechs Ltd. in February, 2017.
The results from the first of these clinical studies were published in Biology of Blood and Marrow Transplantation (Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study, M. Yeshurun et al./Biology Blood Marrow Transplant 21 (2015) 1770-1775).

As previously announced, the data from this study, in which 48 patients received daily doses of 150 milligrams of CBD administered twice daily for seven days prior to the bone marrow transplant procedure and for 30 days after, demonstrated the following results:

• No patients developed acute GVHD while being treated with CBD;
• The rates of grades 2 to 4 acute GVHD by day 100 were 12.1 per cent, compared with 46 per cent in a group of all 101 hematopoietic stem cell transplant recipients who received standard GVHD prophylaxis at the same institution in Israel (the Institute of Hematology, Davidoff Centre, Rabin Medical Centre at Beilinson Hospital) directly prior to the onset of this study;
• CBD was found to be safe and well tolerated.

Kalytera also previously announced the results from the second of the two prior clinical studies, in which 12 patients were administered CBD at a dose of 150 mg administered twice daily from seven days prior to the bone marrow transplant procedure until up to 100 days posttransplantation. In that study, no safety issues were observed, and only 15 per cent of patients in the CBD treatment group developed grades 2-4 acute GVHD, compared with a 46-per-cent incidence at the same institution in the historical group of 101 patients described above.

On July 31, the company met with the United States Food and Drug Administration (FDA). In accordance with the guidance received from the FDA, the company plans to initiate two clinical studies in healthy volunteers this year. These studies will assess certain safety and laboratory parameters of CBD, including the effect of food intake on the absorption of oral CBD and the interaction of CBD with certain anti-fungal drugs. These studies will be conducted in parallel with the company's continuing Phase 2 clinical study in prevention of GVHD, and the data from these studies will be required by the FDA for both the company's prevention and treatment programs.
"Acute GVHD is a severe complication of bone marrow transplant procedures that can lead to permanent impairment of quality of life and even death," said Robert Farrell, president and chief executive officer of Kalytera. "With no FDA-approved therapy for the prevention of acute GVHD, there exists an important unmet medical need that we believe we can address. Based on the positive and encouraging results from the two prior phase 2a clinical studies in prevention of GVHD, we are optimistic that our CBD product will address this unmet need, and will be demonstrated to be a safe and effective means to prevent the onset of acute GVHD."

The commercial opportunity for Kalytera's CBD products for the prevention and treatment of GVHD is large. According to the January, 2018, market forecast report by DelveInsight Perspective, the potential market for a successful product for prevention and treatment of GVHD in the seven major jurisdictions (the U.S., Germany, France, Italy, Spain, the U.K. and Japan) is estimated to be more than $408-million (U.S.) in 2018, and could grow to approximately $1.3-billion (U.S.) by 2027.
If Kalytera's CBD products are approved for the prevention and/or treatment of acute GVHD, the company believes that, given the severe and life-threatening nature of this disorder, treating physicians would not be expected to prescribe anything other than the company's approved formulation of CBD (rather than non-approved CBD that might be available on-line or from other commercial sources).

Kalytera is the exclusive licensee of two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD, and is also the exclusive licensee of pending patent applications in other jurisdictions for the use of CBD in the prevention and treatment of GVHD. In addition to these patents and patent applications, the company has also obtained four orphan drug designations for the treatment and prevention of GVHD in the U.S. and Europe. Such orphan drug designations will provide seven years of market exclusivity in the U.S., and 10 years of market exclusivity in the European Union, upon regulatory approval of the company's CBD products for the prevention and/or treatment of acute GVHD.

The U.S. FDA has recommended that Kalytera apply for both breakthrough therapy and fast-track designations for the company's CBD products for prevention and treatment of acute GVHD, each of which could accelerate the approval process for these products.

About Kalytera Therapeutics Inc.
Kalytera Therapeutics is pioneering the development of CBD therapeutics. Through its proven leadership, drug development expertise and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of CBD medicines for a range of important unmet medical needs, with an initial focus on GVHD and treatment of acute and chronic pain.
We seek Safe Harbor.

 

Why Focus on CBD?

Kalytera Therapeutics (TSXV: KALY) is a clinical-stage pharmaceutical company developing cannabidiol (“CBD”), and next-generation cannabinoid therapeutics, for the treatment of serious and life threatening human disease, with an initial focus on graft versus host disease (“GVHD”).

In our lead program, we are evaluating CBD for the prevention and treatment of graft versus host disease (“GVHD”). Our GVHD program is in late-stage clinical testing. We have an ongoing Phase 2 clinical study in prevention of GVHD, and we expect to initiate a seamless Phase 2-3 pivotal registration study in treatment of acute GVHD later this year. We have two issued U.S. patents covering the use of CBD in the prevention treatment of GVHD, as well as four orphan drug designations for the treatment and prevention of GVHD in the U.S. and Europe.

In addition to our lead program in GVHD, we have also initiated a preclinical program to develop a novel, proprietary cannabinoid compound for the treatment of acute and chronic pain. Our compound consists of a next-generation cannabinoid compound conjugated with naproxen, a generic, non-steroidal, anti-inflammatory drug that is already approved for treatment of pain.

This cannabinoid/naproxen conjugate has potential to become a next generation pain medication, without the risks of addiction or respiratory suppression that exist with opioid analgesics. We have found a way to make this compound water soluble, which will allow for treatment of acute pain in in-patient settings, such as childbirth, short surgical procedures, and post-operative pain care. We have applied for patent coverage in the U.S, Europe and other jurisdictions for this novel cannabinoid compound for the treatment of pain.

Program Highlights

• Two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD
• Four orphan drug designations granted in U.S. and Europe for the treatment and prevention of GVHD
• Four Phase 2a clinical trials complete, one published study demonstrating proof-of-concept
• Urgent unmet need: there are currently no FDA approved therapies for the prevention or treatment of GVHD
• Advancing towards Phase 2b randomized, placebo-controlled clinical studies
• Phase 2 clinical study ongoing in prevention of GVHD, and a seamless Phase 2-3 pivotal registration study in treatment of acute GVHD expected to commence later this year
•  

https://kalytera.co/about/#cbd

RNC Doubles Strike Length of High Grade Coarse Gold Structure from New Development in Discovery Area - "Fathers Day Vein"

2018-09-16 18:06 ET - News Release

Recent development recovers a 43kg specimen stone containing an estimated 1,100 ounces of gold

TORONTO, Sept. 16, 2018 /CNW/ - RNC Minerals (TSX: RNX) ("RNC"), is pleased to announce that it has doubled the strike length of this high grade coarse gold structure, to approximately 10 metres, after restarting development in the new high grade gold discovery area "Fathers Day Vein" at its Beta Hunt Mine in Australia (see RNC news release dated September 9, 2018). Airleg development towards the initial discovery area intersected the structure last Friday and the break through into the original discovery area is expected today. A 43kg specimen stone containing an estimated 1,100 ounces of gold and a second 7kg specimen containing 190 ounces was recovered from this most recent development. An updated estimate of ounces from the Fathers Day Vein is expected to be provided later this week after final outturns from last week's shipments to the Perth Mint have been received and initial estimates from the recovery and shipment of coarse gold and specimen stones from the most recent development are completed. Final numbers from this most recent development should be known within 2 weeks once all processing by the Perth Mint has been completed.

"The Fathers Day Vein delivers additional gold and cash flow from this further extension with additional potential up-dip still to be developed. I am looking forward to the production estimates incorporating these additional ounces expected later this week. The Beta Hunt team has done a great job moving the operation forward over the last 12 months and I congratulate every person working at Beta Hunt for the incredible Fathers Day Vein discovery last week. RNC is currently developing plans to unlock the high-grade gold potential of the mine which remains largely unexplored." said Mark Selby, President and CEO of RNC.

Airleg development resumed last week and began driving towards the current face on the left side of the initial discovery area (see Figure 1) and intersected the structure last Friday (September 14, 2018) effectively doubling the strike length of the high grade coarse gold structure. The structure remains open up dip with a substantial amount of coarse gold remaining in the face (see Figure 2)
Fathers Day Vein Discovery (see RNC news release September 9, 2018)

This discovery was made on Father's Day in Australia and has been named the "Fathers Day Vein".
RNC is the first owner of the Beta Hunt Mine to focus on drilling deeper in the Lunnon Basalt in its search for gold, and therefore the first owner to discover and mine gold from newly discovered coarse gold located entirely within the Lunnon Basalt. Previous bonanza grade specimen stone occurrences at Beta Hunt were associated with the nickel-sulphide bearing contact between the Lunnon Basalt and the overlying Kambalda Komatiite where nickel mining has been focused by RNC and previous operators.

Based on diamond drilling and underground mapping, there are two or more Lunnon sediment bands which are a zone of narrow (< 0.3m), strongly pyritic black shale horizons positioned approximately 150m stratigraphically below the Lunnon Basalt/Kambalda Komatiite nickel contact (see Figure 2 below).  This sediment horizon is well documented in published literature and is recognized as a marker unit in differentiating the Upper and Lower Lunnon Basalt. The sediment horizon is now also interpreted by geologists at the Beta Hunt Mine as a zone of chemical interaction between the gold bearing fluids and pyritic sulfides, which under the right conditions, allow large gold crystal growth and extremely high-grade gold deposition.  This interpretation is based on geological mapping and interpretation of structures on 14 and 15 Levels, where 1,500 oz of specimen gold was discovered and mined in the second and third quarter. The structure found last week is located in a dilation zone which contains sheared pyritic sediments, porphyry and Lunnon basalt and large amount of coarse gold and specimen stone.

Understanding the depositional model for this new gold mineralization provides potential for future exploration and discovery of high grade gold material at the sediment marker layer, which runs along all known shear structures located at Beta Hunt Mine.

The Lunnon Basalt contains a subaqueous sediment horizon which well documented in published literature and is recognized as a marker unit in differentiating the Upper and Lower Lunnon Basalt. Whereas the Upper has lower MgO content than the Lower sequence. The sediment horizon is now also interpreted by geologists at the Beta Hunt Mine as a zone of chemical interaction between the gold bearing fluids and pyritic sulfides, which under the right conditions, allow large gold crystal growth and extremely high-grade gold deposition. Understanding the depositional model for this new gold mineralization provides potential for a completely new level of high grade gold specimen stone to be discovered.
This interpretation is based on geological mapping and interpretation of structures on 14 and 15 Levels, where 1,500 oz of specimen gold was discovered and mined in Q2/Q3. The structure found in early September is located in a dilation zone which contains sheared pyritic sediments, porphyry and Lunnon basalt and a large amount of coarse gold and specimen stone. This underlines the potential of future exploration and discovery of coarse gold material grading in several ounces per tonne. The sediment marker layer, which runs along all known shear structures located at Beta Hunt Mine, provide significant exploration potential in the near future.
The disclosure of scientific and technical information contained in this news release has been approved by Kevin Small, Vice-President, Project Development of RNC, a Qualified Person under NI 43-101.

About RNC MineralsRNC is a multi-asset mineral resource company with a portfolio of gold production and nickel, cobalt, assets and exploration properties. RNC has a 100% interest in the producing Beta Hunt gold and nickel mine located in Western Australia where a significant high grade gold discovery was recently made. RNC also has a 28% interest in a nickel joint venture that owns the Dumont Nickel-Cobalt Project located in the Abitibi region of Quebec which contains the second largest nickel reserve and eighth largest cobalt reserve in the world. RNC owns a 35% interest in Orford Mining Corporation, a mineral explorer focused on highly prospective and underexplored areas of Northern Quebec and the U.S. Carolina Gold Belt. RNC has a strong management team and Board with over 100 years of mining experience at Inco and Falconbridge. RNC's common shares trade on the TSX under the symbol RNX. RNC shares also trade on the OTCQX market under the symbol RNKLF.

Cautionary Statement Concerning Forward-Looking Statements
This news release contains "forward-looking information" including without limitation statements relating to the liquidity and capital resources of RNC, production guidance and the potential of the Beta Hunt and Reed mines as well as the and the potential of the Dumont development project and Orford Mining's Qiqavik, West Raglan, Jones-Keystone Loflin and Landrum-Faulkner exploration properties.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of RNC to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could affect the outcome include, among others: future prices and the supply of metals; the results of drilling; inability to raise the money necessary to incur the expenditures required to retain and advance the properties; environmental liabilities (known and unknown); general business, economic, competitive, political and social uncertainties; accidents, labour disputes and other risks of the mining industry; political instability, terrorism, insurrection or war; or delays in obtaining governmental approvals, projected cash operating costs, failure to obtain regulatory or shareholder approvals. For a more detailed discussion of such risks and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, refer to RNC's filings with Canadian securities regulators, including the most recent Annual Information Form, available on SEDAR at www.sedar.com.
Although RNC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and RNC disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE RNC Minerals

Goldrea signs LOI with XChemistry for pot testing

2018-08-29 13:27 ET - News Release

Mr. Jim Elbert reports
GOLDREA ENTERS INTO LETTER OF INTENT WITH XCHEMISTRY, A PROVIDER OF COMPLIANCE TESTING FOR CANNABIS PRODUCTS
Goldrea Resources Corp. has signed a binding letter of intent (LOI) with XChemistry Holdings Inc., headquartered in San Diego, Calif. The primary business of XChemistry Holdings is focused on providing compliance testing for cannabis products. On Jan. 1, 2018, new cannabis guidelines became effective in California after legalizing its recreational use. It is XChemistry Holdings' plan, partnering with Goldrea Resources, to build a laboratory testing facility in the Greater Los Angeles Area. The lab is expected to be completed in a minimum of four months, and after city and state requirements are fulfilled, be fully operational approximately two months following.
The market for cannabis products in California has been forecasted to surpass five billion dollars in 2019. California mandates that samples from every type of cannabis be tested for impurities from a licensed laboratory. At a cost of estimated $400 per sampling, this provides a lucrative source of revenue for an efficient and high capacity facility the XChemistry Holdings team will be building. Only lab-tested products may be sold by licensed retailers as of July 1, 2018. With this new regulation in effect, there is a shortage of testing services, causing long wait times for results, leading to delays in selling of product and possible spoilage. This provides an immediate market for XChemistry Holdings participation. The cost of construction of the lab and becoming operational is estimated to be three million dollars (CDN.)

XChemistry Holdings has an experienced group of experts in the field that will construct and operate the new facility. Chuck Nokes, CEO of XChemistry Holdings, states, "We are excited to have found the right fit with Goldrea and now look forward to quickly moving this LOI forward to a Definitive Agreement and begin the construction of a working laboratory that will fulfill a percentage of a massive need in the coming years. We fully expect to play a major role in this field, along with future projects in DNA and non-cannabis application. Our planned partnership with Goldrea gives us the public platform from which to build out our business plan efficiently and effectively.
Under the LOI, Goldrea will acquire all of the issued and outstanding shares of XChemistry Holdings in exchange for issuing Goldrea shares to the Xchemistry shareholders which collectively will equal approximately 10% of the issued and outstanding shares of Goldrea at closing of the transaction. The value of this position is deemed to be approximately $320,000 based on Goldrea's shares outstanding priced at ten cents. Other key terms of the deal include:

• The Company must complete an equity financing of at least $2 million CDN, concurrent with the closing of the acquisition.
• Xchemistry will be entitled to nominate one person to Goldrea's board of directors.
• Goldrea will assume certain liabilities of Xchemistry.

After the closing of the acquisition, Xchemistry (as a wholly-owned subsidiary of Goldrea) will enter into 3-year management contracts with Chuck Nokes as CEO, Zac Simmar as President and CFO, and Dr. Charles Sailey as CSO.

XChemistry Holdings's founders will receive a total of US$150,000 cash bonus when Xchemistry attains net profits of at least US$500,000 over a trailing six-month period, and bonuses in the form of share issuances equal (collectively) to 10% of the issued and outstanding Goldrea shares at the time Xchemistry reaches the milestones of $5 million, $15 million and $25 million of annual revenues respectively, provided that net profits is at least 10% of the revenues attained. All benchmarks being reached would result in a 40% ownership of Goldrea by XChemistry Holdings.
Each party must be satisfied with its due diligence investigations of the other before completing the proposed transaction. The proposed transaction is subject to obtaining all necessary consents including shareholder and regulatory approvals. Construction of the laboratory is anticipated to begin in fourth quarter 2018 and end in March 2019.

Jim Elbert, President and CEO of Goldrea, states, "After much planning and investigation, we are quite satisfied that the acquisition of XChemistry represents an exciting opportunity for Goldrea to enter the cannabis sector. We look forward to further growth once we firmly establish this core business servicing a regulatory aspect of this burgeoning industry."
We seek Safe Harbor.

GAR lists Bitcoin Cash for purchase

2018-08-28 14:27 ET - News Release

Mr. Mark Binns reports
NETCOINS LISTS BITCOIN CASH (BCH)
GAR Ltd., doing business as Netcoins, has listed Bitcoin Cash (BCH), available for immediate purchase, through its over-the-counter private brokerage services business and its over 21,000 retail locations in Australia, Europe and Canada. To purchase BCH now, please contact Netcoins at 844-515-2646 or OTC@goNetcoins.com. BCH is currently No. 4 by market cap for cryptocurrencies, according to the Coin Market Cap website.

"Adding BCH brings us to having six of the top seven coins available via Netcoins," said Mark Binns, chief executive officer of Netcoins. "With just EOS left among the top seven coins, we are giving investors a compelling reason to use the Netcoins network for all their crypto needs, whether via OTC or via our strong retail network."

About GAR Ltd.
GAR is in the business of developing software to make the purchase and sale of cryptocurrency easily accessible to the mass consumer and investor through brokerage services.
We seek Safe Harbor.

INCA GOLD

BACK ON THE TRAIL OF INCA ONE

It's no surprise that the world markets always turn to gold in good times and in bad and the hoarding of gold is not limited to countries or corporations. The markets soften and then weaken in a not always predictable pattern but eventually everyone always heads back to gold. Either you are stashing away profits from pot deals or you are looking for stability in an uncertain economic climate, we all feel safer with a percentage of our portfolio in gold.

Over the years I have traveled to and toured mines in Colombia, Guyana, Argentina, Chile, Mexico and Peru and invested as far away as Borneo and Africa. I like to be "boots on the ground" if I am making a significant investment in a mining company but it's not always possible to drop everything and fly over to see the site. I meet with the management teams and other large investors as well and see who is holding the lions share of the stock. You will often here brokers and large investors talk about poor share structure as one of the negatives to look for when investing. This not only means how many shares are out but who holds them and is there a large overhang from previous financing's or debt settlement. Ask yourself whats stopping this stock from going significantly higher and often the answer is tired share holders or flippers due to the over liquidity situation the company is in. The numbers can be deceiving though and 200 million shares out does not always mean 200 million in the public float.

Institutional buyers usually pick strong stories and build positions for years down the road. They think long term and often very long term so their positions are not likely to enter the market as the share price rises. Day traders will often set price targets and start liquidating when those targets are hit no matter how strong the stock looks. If a company has only 20 million shares out it's hard for me to take 9% without causing a significant rise in the share price unless I do it over several months. A lack of liquidity can be a roadblock for investors who see the difficulty in buying equal to selling since the market is too tight, not to mention the premium you pay just to play along.

I have made some of my largest gains on mining stocks but early stage drilling companies are always looking for cash and continually go back to the market to do more financing and dilution on the stock. This in turn adds more warrants and options, which also dilute the stock. We have all seen the "wash-rinse-repeat" cycle from junior miners and unless you have a contact you are investing blind with exploration companies. Take the time to watch the interviews with CEO's of exploration companies and listen to how they respond to when they will be producing. Some will dodge the question while others will throw out a number that's probably half way to production. The odd CEO will admit they are at least 10 years to production and that they hope some bigger player buys them out before then. In other words they have no intention to produce, they just want to polish the apple and sell it to someone else and turn a profit for themselves and their shareholders.

A few years ago I met up with Ed Kelly from Inca One IO.V in San Ignacio, Peru and tagged along with his crew to tour their property. At the time the company was meeting with the locals and filing for permits and the locals coffee farmers played an active roll in seeing the project move forward. Well the end result was more meetings and delays as local political figures felt they weren't consulted or compensated for their opinion. The plan appeared to jump off the rails and this was just part of the business of mining in most countries. The oddest thing is Peru is the gold capital and has been for centuries but if you don't play your cards right and grease the right political wheels then you just sit and spin.

By random chance I met with them again at an investor event and was amazed at the changes the company had made to their approach in Peru. The company has their own processing plant now and rain or shine they are making money every day. They went ahead and made agreements with miners who were having a hard time trucking out their ore for processing and gave them a go-to spot that insures their ore is produced and they are quickly paid so they can keep the cycle going. Now there are no worries about drill targets or compliance estimates and if they will actually produce. The risk is now taken on by miners who are permitted and operating but have no access to processing. Years ago I remember reading about picks and shovel investing and how you are better off selling equipment to exploration companies since they are always looking and always spending money but not everyone hits pay dirt. Even the unlucky mining companies need equipment. This is the same type of thinking only better because now we know there will always be processing going on and the company takes its cut and then the next guy unloads.

“During the gold rush its a good time to be in the pick and shovel business”

― Mark Twain

Inca One just negotiated another processing plant deals that will see a large spike in daily operations and that combined with cost cutting measures at the first plant will see high revenue numbers in the coming months. Inca One Gold Corp.'s gold production in July, 2018, reached approximately 1,291 ounces as compared with 844 ounces in July, 2017, an increase of 53 per cent year over year (YOY). 

July 17, 2018 Inca One announce they had  acquire the Koricancha Processing Facility in Peru which will push their daily production to 500 TPD from the 100-150 TPD they get currently from the Chala One milling facility located in Chala, Southern Peru.

Highlights upon completion of Transaction for Inca One shareholders include:

• Establishes Inca One as the leader for publicly listed gold processing companies in Peru, with 450 TPD permitted capacity.
• Immediately more than doubles throughput to approximately 250 TPD, which diversifies Inca One’s operating platform.
• Additional 200 TPD of available capacity for future growth.
• Establishes Inca One as a consolidator in the industry with its second plant in operation.
• Economies-of-scale opportunities and several strategic benefits of having two plants within a 50km radius, including the potential for centralized purchasing, crushing, desorption and smelting services.
• Combined working capital of over US$5 million.
• Equinox becomes a new significant shareholder.

Inca One President and CEO, Edward Kelly, stated, “The acquisition of the producing Koricancha Mill is a strategic and transformative acquisition for Inca One.  It instantly elevates the Company from a small producer to a major player among publicly traded gold processing companies.  Inca One significantly increases its permitted capacity and more than doubles our current throughput. The transaction is aligned with our long-term growth objectives and is an important milestone in the consolidation we foresaw in the processing space. We look forward to working with the operating team at Koricancha. We also welcome Equinox as a business partner and significant shareholder in Inca One going forward.”

Christian Milau, CEO of Equinox, commented, “We are pleased to partner with Inca One on this transaction. While Koricancha is no longer a core asset for Equinox, it is highly complementary to Inca One’s existing operations in Peru and will deliver both increased scale and operating efficiencies. We intend on being a long-term and supportive shareholder of Inca One as their experienced team focuses on establishing the Company as an industry leader in the Peruvian gold milling space.”

The closing of the Transaction is subject to approval by the TSX Venture Exchange and satisfaction or waiver of other customary conditions. FULL STORY

 *Full Disclosure: I am invested in Inca One IO.V

Inca One closes acquisition of Koricancha plant

2018-08-21 07:39 ET - News Release

Mr. Edward Kelly reports
INCA ONE GOLD COMPLETES THE ACQUISITION OF KORICANCHA PROCESSING FACILITY IN PERU
Inca One Gold Corp. has finalized the purchase of Anthem United Inc., which owns 90.14-per-cent interest in the 350-tonne-per-day (tpd) Koricancha ore processing facility in Peru, from Equinox Gold Corp. and certain minority shareholders. Please refer to Inca One's press release dated July 17, 2018, for complete details on the terms of the acquisition.
Highlights of acquisition for Inca One shareholders include:

• Combined 450 tpd permitted capacity;
• Additional 200 to 250 tpd of available capacity for future growth;
• Economy-of-scale opportunities with two plants in nearby proximity;
• Combined working capital of approximately $5-million (U.S.);
• Equinox becomes a new significant shareholder.

The total purchase price for the Koricancha acquisition was approximately $16.3-million satisfied through the issuance of an aggregate of 110,050,225 shares at a deemed price of 5.5 cents per share, $7.5-million in cash or shares payable over three years at the company's option, $1.5-million payable in cash on the second anniversary of closing and the balance on the third anniversary, subject to certain working capital adjustments. The purchase price includes certain IGV tax credits which will be split between Inca One and Equinox as collected. In connection with the transaction, the 3.5-per-cent gold stream currently payable by Koricancha was terminated and, as a result, future production from Koricancha will not be subject to any precious metal streams or royalties thereby maximizing revenues for the company's shareholders. As a result of the Koricancha acquisition, both Equinox and SA Targeted Investing Corp. (SATIC) will both hold approximately 19.9 per cent of Inca One's issued and outstanding shares. No finders' fees were paid in relation to the acquisition.
"The closing of this acquisition of the producing Koricancha mill is a strategic and transformative acquisition for Inca One," repeated president and chief executive officer, Edward Kelly. "It instantly increases our footprint in Peru and allows us to grow our sales and earnings without significant and time-consuming capital spending and delays in permitting."
Koricancha is a custom-built, fully operational, industrial gold ore processing facility, featuring a carbon-in-leach gold circuit, strategically situated in the Arequipa region of Peru. It is located at sea level, fully serviced by excellent infrastructure just 10 minutes from the Pan American Highway, within the Nazca-Ocona gold belt in Southern Peru. It is built out and permitted for 350 tpd and has been operating at an average of approximately 135 tpd since January, 2018. It has been servicing the small-scale mining sector of Peru for three years and has a stockpile of material currently being processed.

Early warning
In connection with the transaction, Equinox has acquired 51,269,708 Inca One shares and SATIC has acquired 51,269,708 Inca One shares, each representing 19.99 per cent of the Inca One Shares that are issued and outstanding upon completion of the transaction, at a deemed price of 5.5 cents per share. Prior to completion of the transaction, neither Equinox nor SATIC owned any Inca One shares or other securities of Inca One. Equinox and SATIC are acquiring the Inca One shares for investment purposes only. Depending upon market and other conditions, or as future circumstances may dictate, either or both of Equinox and SATIC may, respectively, from time to time, increase or decrease their holdings of Inca One shares or other securities of Inca One.
In connection with the closing of the transaction, Equinox and Inca One have entered into a nomination rights agreement pursuant to which, among other things, so long as Equinox beneficially owns at least 10 per cent of the outstanding Inca One shares it will have the right to nominate one director to Inca One's board and to participate in certain offerings of securities by Inca One to maintain its pro rata ownership interest.

This portion of this news release is issued pursuant to National Instrument 62-103 -- The Early Warning System and Related Takeover Bid and Insider Reporting Issues of the Canadian Securities Administrators, which also requires an early warning report to be filed with the applicable securities regulators containing additional information with respect to the foregoing matters. A copy of the early warning reports of Equinox and SATIC will be available on Inca One's issuer profile on SEDAR. Equinox's head office is located at Suite 730, 800 West Pender St., Vancouver, B.C., V6C 2V6, and Equinox can be contacted at 604-558-0560, attention Pam Kinsman, to obtain a copy of its early warning report.

About Inca One Gold Corp.
Inca One is a Canada-based mineral processing company. The company's activities consist of the production of gold and silver from the processing of purchased minerals located in Peru. Peru is the sixth-largest producer of gold in the world and the Peruvian government estimates the small-scale mining sector accounts for a significant portion of all Peruvian gold production, estimated to be valued at approximately $3-billion (U.S.) annually. The company purchases its minerals from government registered small-scale mining producers from various regions and processes it at its Chala One milling facility located in Chala, southern Peru.
We seek Safe Harbor.

Goldrea Resources in talks for cannabis testing

2018-08-17 09:51 ET - News Release

Mr. James Elbert reports

GOLDREA PROVIDES CORPORATE UPDATE
Goldrea Resources Corp. has provided the following update.
The company has worked diligently with Tabu as per the letter of intent announced on June 18, 2018. While Tabu has not yet met the conditions set in the letter of intent expiring Aug. 20, 2018, it continues developing inroads into the cannabis space, and the two companies will keep dialogue open for a mutual agreement, given the positive relationship that has been built. In addition, and not in conflict with Tabu, Goldrea is in late stages negotiation with a service company in business of providing testing of cannabis to meet state regulations. The operations would be in California to provide testing to various producers of cannabis and cannabis products. Upon the completion of an agreement, the company looks forward to making a further announcement in more detail.

Jim Elbert, president and chief executive officer, reports: "There are great opportunities in the cannabis space, and Goldrea has worked to find the right opportunity that fits with the company's vision as a sizable completed deal could change the company profile in a dramatic way. We are confident that some positive developments will be completed in the near term. In the meantime, Goldrea has kept its mining concerns current and, in fact, have improved upon them. These properties have significant value at the core of Goldrea's present worth."

Goldrea has invested another $25,000 into the Cannonball property with the funds earmarked for aerial magnetic surveying. This is anticipated to bring the property into National Instrument 43-101 reporting. The Lift lithium property in the Clayton Valley in Nevada is current until September, 2019, and the company will be actively seeking a partner, given the recent renewal of interest in the sector and area. The two properties of gold and lithium in Quebec are in good standing, and the company is accepting inquiries of interest from potential buy/joint venture partners.
We seek Safe Harbor.

Goldrea Resources firms up Tabu Equity deal

2018-06-18 12:22 ET - News Release


Mr. James Elbert reports
GOLDREA AND TABU COMMIT TO FINAL AMALGAMATION
Goldrea Resources Corp. has signed an amalgamation agreement with Tabu Equity Investments. The terms of the Agreement will include the entirety of Tabu's outstanding twenty-seven million shares on a one for one basis with Goldrea, to be taken out of Goldrea's treasury shares. Goldrea will acquire all of Tabu's assets, including all contracts complete and pending. Tabu is responsible for raising a minimum of one million dollars of investment as operating funds to launch various projects Tabu has in play.

Given the successful passing of cannabis legislation in Parliament's Senate, a positive environment exists as final passage is expected in the House of Commons in the near months. This timing works well for the merging of Goldrea and Tabu in anticipation of final approval of the Amalgamation subject to shareholders and the Exchange. Next year's cannabis industry in Canada is estimated to be more than four billion dollars and 2020 is projected to be over six billion. Goldrea's goal is to ethically embrace this opportunity and explore the varied benefits cannabis can offer.
 
Jim Elbert, President and CEO of Goldrea states, "We are looking forward with the partnering with the vibrant team of Tabu, and their wide swath of contacts and working associations in the cannabis industry. Tabu's business plan, which is aggressive in penetrating this burgeoning sector, can be accelerated under the umbrella of the public company of Goldrea, expanding exposure both nationally and internationally."
 
We seek Safe Harbor.

FULL STORY 

Cielo receives environmental permit for Alta. refinery

2018-06-11 08:38 ET - News Release

Mr. Don Allan reports
CIELO RECEIVES REQUIRED PERMIT FROM THE ALBERTA GOVERNMENT TO CONSTRUCT AND OPERATE ITS HIGH GRADE RENEWABLE DIESEL REFINERY IN ALDERSYDE, ALBERTA
Late in the day on Friday, June 8, 2018, Cielo Waste Solutions Corp. received its permit from the Ministry of Environment and Parks (Alberta) pursuant to the Environmental Protection and Enhancement Act that will allow for the operation of its first commercial refinery in Aldersyde, Alta. Don Allan, president and chief executive officer of Cielo, stated: "Receipt of the EPEA permit is a momentous milestone which allows us to now proceed with commissioning and placing our transformational high-grade renewable diesel refinery on production. It is anticipated that the regulatory permitting approval process will be significantly shortened with each new site that is applied for, especially within the province of Alberta. We are now more confident than ever that we will have our refinery up and running on a continuous flow basis before the end of this month." Mr. Allan further commented: "We are looking forward to being able to showcase to the world in the coming weeks and months our technology that utilizes our proprietary processes to convert, on an extremely cost-effective basis, multiple different garbage-derived feedstocks, including all plastics, sorted municipal solid waste (garbage), wood and agriculture waste, tires, and virtually any other cellulous waste product, into high-grade renewable diesel. Our refineries are being engineered to be the greenest refineries on the planet which will benefit generations to come by being able to convert landfills into renewable fuels."

Cielo's strategic plan calls for building multiple modular refineries around the world, offsetting landfills and other feedstock supplies. Cielo intends to focus initially on building additional refineries in Alberta to fill the Canadian mandated demand for renewable diesel, almost all of which is currently having to be imported into Canada. In the coming months and years, Cielo's goal is to replace as much as possible of the imported mandated demand, which management believes to be about 650 million litres a year, with its high-grade renewable diesel fuel. The renewable diesel that is going to be produced at the company's Aldersyde refinery is forecast to receive approximately a 25-per-cent premium over biodiesel pricing. In addition, as a result of Cielo's feedstock being waste streams, with in some cases negative acquisition costs, versus biodiesel that uses food feedstocks, Cielo's management believes that Cielo will not have to rely on government subsidies to be extremely profitable.

It will be higher grade and lower in sulphur and water, allowing year-round supply and longer shelf life. The refinery will initially be using wood waste as its feedstock that is being acquired pursuant to a multiyear feedstock agreement with Mountainview Eco Products. Mark Haldane, president of Mountainview, commented: "We are pleased to have been selected as the initial supplier of feedstock for Cielo's environmentally friendly Aldersyde refinery. Being able to sell a waste product that is challenging for all North American sawmills and pulp mills to dispose of, makes sense to us both from a business and an environmental standpoint. We continue to be extremely pleased to be a part of

Cielo's strategic plan."
Input and output numbers will be disclosed once Cielo's Aldersyde refinery is up and running on a continuous flow basis. As a result of multiple engineering enhancements that were implemented during construction of the company's continuous flow refinery at Aldersyde, Cielo's management is anticipating at this point in time that the output of high-grade renewable diesel from the company's phase 1 refinery will meet and or exceed the originally contemplated output of 350 litres per hour of high-grade renewable diesel.

About Cielo Waste Solutions Corp.
Cielo Waste Solutions is a publicly traded company with its shares listed to trade on the Canadian Securities Exchange (CSE) under the symbol CMC. Cielo holds the exclusive licence for the global rights to a transformational, patent-pending technology engineered to convert garbage-derived feedstocks to renewable diesel, at a significantly lower cost than biofuel companies. With landfills being one of the world's leading contributors to greenhouse gas emissions and being projected to double in size over the next seven years, Cielo can potentially resolve this crisis, on a cost-effective basis, by converting multiple different garbage-derived feedstocks, including sorted municipal solid waste (garbage), wood and agriculture waste, tires, blue box waste, all plastics and virtually any other cellulous waste product into high-grade renewable diesel.
We seek Safe Harbor.

Goldrea closes financing at $145,000, grants options

2018-05-14 17:56 ET - News Release

Mr. James Elbert reports
GOLDREA GRANTS STOCK OPTIONS AND CLOSES PRIVATE PLACEMENT
Goldrea Resources Corp. has granted an aggregate of 700,000 stock options to certain directors, officers, employees and consultants pursuant to the company's stock option plan. The options have an exercise price of 10 cents per share and an expiry date of May 14, 2023.

In addition, the company had previously announced the closing of a first tranche of a private placement which raised $145,000 from the sale of 725,000 units. Management has decided there will be no further tranches and the private placement of the 20-cent units is now closed. Funds raised in the private placement will be used for general working capital and all securities issued under the offering will have a four-month hold period.

The company is continuing its negotiations with Tabu Equity Investments Inc. with respect to a business combination between the parties. While an independent valuation of their company is being conducted, Tabu has continued to increase associations and agreements within the cannabis sector. An update of that activity can be viewed at the Tabu website. Both Goldrea and Tabu look forward to a rewarding relationship over the coming years and announcing the definitive agreement in the near term.

We seek Safe Harbor.

Canyon Copper cheers Sask. support for Creighton work

2018-04-26 10:31 ET - News Release

Mr. Stephen Wallace reports

SUPPORT FROM SASKATCHEWAN GOVERNMENT FOR EXPLORATION IN CREIGHTON SASKATCHEWAN AREA
Canyon Copper Corp. has noted that the government of Saskatchewan is creating a four-year mineral development strategy that targets Canyon Copper's exploration areas southwest of Creighton, Sask., and Flin Flon, Man. This is an area that the Government of Saskatchewan states that it holds high potential for base metals, precious metals and diamonds. The Company has been informed by letter from the Government of Saskatchewan of the planned initiative. Follow link below:
https://www.canyoncc.com/site/assets/files/3716/ccc_sask_mineral_development_strategy_letter.pdf
The focus of this intuitive is on exploration, including targeted geophysical surveys, geoscience work by the Saskatchewan Geological Survey and a mineral exploration incentive aimed at exploration activities, particularly drilling. A key emphasis of the strategy will be to encourage base metal exploration in the Creighton-Denare Beach area, which has had a long history of base metal mining and processing.

Canyon now holds a total of 7,280 hectares south west of Flin Flon, Manitoba and Creighton, Saskatchewan within the Flin Flon Greenstone Belt. This is an area of renewed mineral exploration interest with the Federal and Saskatchewan governments signing an agreement in December 2017 worth approximately $2million to conduct an airborne geophysical survey southwest of Creighton. ( http://www.cbc.ca/news/canada/saskatoon/creighton-mine-exploration-flin -flon-1.4512485 ) This airborne geophysical portion of the Mineral Development Strategy is underway with the beginning of the tendering process to determine which companies or providers will conduct the survey. It is expected the details of the Mineral Exploration incentive including a partial rebate of drilling expenditures will be outlined in the near future. ( http://www.thereminder.ca/news/local-news/tenders-out-for-sask-mine-exploration-initiative-1.23208516 )

In 2018, the Fraser Institute Annual Survey of Mining Companies ranked Saskatchewan the 2nd most attractive jurisdiction in the world for mining investment. Stephen Wallace, President and CEO of Canyon stated, "Canyon Copper agrees with the high ranking of Saskatchewan by the Fraser Institute. Since the Company began working in Saskatchewan in May 2017 the support by the Saskatchewan Government has been first class. And the Mineral Development Strategy reinforces the benefits of exploration and mine development in Saskatchewan."

Drilling Update
In March 2018 Canyon completed a 4-hole diamond drill program totaling 1,446 metres with three drill holes completed at the past producing Rio mine and one at the past producing Newcor mine. Drill logging and sampling is underway and initial results are expected in the first half of May 2018.
International Mining Investment Conference

Canyon Copper is also pleased to announce the Company will be exhibiting at the International Mining Investment Conference taking place May 15-16 in Vancouver at the Vancouver Convention Centre East.

Qualified Person
Stephen Wallace PGeo is the Company's designated Qualified Person within the meaning of National Instrument 43-101 and has reviewed and approved the technical information contained in this news release.

We seek Safe Harbor.

Alliance Growers plans to expand project

Alliance Growers expands partnership with Pharmagreen

2018-04-25 10:44 ET - News Release

Mr. Dennis Petke reports
ALLIANCE REPORTS CBD PRODUCTION ECONOMICS FROM CANNABIS BIOTECH COMPLEX
Alliance Growers Corp. has made vertically integrated additions to its revenue model and profit potential through expansion of its business partnership with Pharmagreen. The two companies have agreed to the joint development of the proprietary high-yield cannabidiol (CBD) DANA strain in a profitable industrial hemp operation that begins with tissue culture plantlets produced and grown on what is now referred to as the Cannabis Biotech Complex on the property in Mission, B.C.
Alliance and Pharmagreen will jointly execute on a two-stage commercial hemp operation to generate $60M in revenue on an annual basis in addition to the revenue generated from tissue culture sales. The advantage Alliance has is two-fold. First the Company has the advantage of starting off with genetically perfect and disease and bug free "female only" plantlets generated from the Botany Centre, the basis of the Cannabis Biotech Complex. Second the proprietary CBD DANA strain will provide a significant yield in CBD production from hemp.

According to Pharmagreen, the content of the CBD DANA strain is significantly higher than traditional hemp strains which typically have 1% CBD content. Additional increase in the CBD yields is achieved when no males are present to pollinate the females which increases the flower content by an additional 80%. The Cannabinoids are mainly produced in the flower portion of the female plant, therefore planting female plantlets instead of planting from seed eliminates the males and keeps the flower production at maximum. The commercial production of hemp starts with planting 200,000 female-only tissue cultured plantlets of the proprietary CBD Dana strain in 5 acres of glass greenhouses. Stage two involves moving the plants to a leased, secure open field of a minimum 20 acres with a contract hemp farmer. The 200,000 plants will yield approximately 100,000 kilos of CBD flower which in turn will yield 3,000 kilos of 99% CBD Crystals of the proprietary Dana Strain. At approximately $20,000 per kilo, that yields $60 million in gross revenue with costs ranging from $20 million to $30 million depending on the lease and contract farming arrangement and the cost of extraction.

"Expanding our partnership with Pharmagreen by co-development of the commercial hemp operation provides for much greater revenue and profit sharing opportunity. It expands the business model where Alliance Growers already has an incredible investment with the largest Canadian state-of-the-art tissue culture production facility- the Cannabis Botany Centre. This partnership adds relationships with cultivators and extractors to assist in building vast revenue model and exceptional profit potential. It is one of the best triangular business models for the Cannabis industry, it truly stands out," exclaimed Dennis Petke, Alliance Growers' President and CEO.

About Alliance Growers
Alliance Growers is a diversified cannabis company driven by the Company's 'Four Pillars' Organization Plan &amp;#8212; Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development. Alliance Growers has finalized its a new business partnership with WFS Pharmagreen Inc., to jointly develop and operate a 40,000-square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the "Chibafreen Invitro Plant Production System", which assures consistent composition and purity of each plantlet for the growers.

Alliance Growers has entered into an exclusive agreement to acquire a late stage licensed producer applicant, Biocannatech, to become a licensed producer under Health Canada's access to cannabis for medical purposes regulations ("ACMPR") in Quebec. Alliance Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required to obtain a growing license. Once Health Canada is satisfied with a successful crop, Alliance Growers will be granted its distribution license. This acquisition allows the Company an opportunity to become a licensed producer in the Province of Quebec and gain an in-road to provide tissue culture plantlets to all licensed producers in Quebec.

Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.
We seek Safe Harbor.

Int'l Battery closes $1.11-million placement tranche

2018-04-13 14:35 ET - News Release

Mr. Logan Anderson reports
INTERNATIONAL BATTERY METALS CLOSES FIRST TRANCHE OF NON-BROKERED FINANCING FOR GROSS PROCEEDS OF $1,117,744 AND INCREASES NON-BROKERED AND BROKERED FINANCING
International Battery Metals Ltd. has closed the first tranche of its non-brokered private placement by issuing 3,193,554 units, for aggregate gross proceeds of $1,117,744.
Each unit consists of one common share of the company and one-half of one non-transferable share purchase warrant. Each full warrant entitles the holder to purchase one additional common share of the company at a price of 70 cents per common share for a period of two years, subject to an acceleration provision, as described in the company's news release dated March 9, 2018.

Due to strong investor demand, International Battery has also increased the size of the non-brokered financing to four million units, resulting in gross proceeds to International Battery of up to $1.4-million. After closing the first tranche of the non-brokered private placement, 806,446 units are available. The brokered private placement has also been increased to six million units for maximum gross proceeds of $2.1-million.

Cash finders' fees of $58,499 were paid to two finders in connection with the closing of the first tranche of the private placement. The finders' fees represented 8 per cent of gross proceeds raised on certain subscriptions. The net proceeds from the first tranche of the non-brokered private placement will be used for working capital purposes. All securities issued in connection with the private placement are subject to statutory hold periods in accordance with applicable securities laws.
Further to International Battery's news release dated March 27, 2018, the company also announces that the Canadian Securities Exchange has approved its warrant incentive program. However, due to the number of warrantholders, the company will not be applying for the warrants to be listed and posted for trading on the CSE.
We seek Safe Harbor.

Lithoquest recovers microdiamonds from North Kimberley

2018-04-02 12:17 ET - News Release

Mr. Bruce Counts reports
LITHOQUEST DIAMONDS INC. RECOVERS MICRO-DIAMONDS FROM OUTCROP SAMPLE
Lithoquest Diamonds Ltd. has recovered microdiamonds from a sample of highly weathered outcrop at target 0702 on its 100-per-cent-owned North Kimberley diamond project, located in the northern region of Western Australia. Three microdiamonds were recovered from a 10.06-kilogram rock sample submitted for kimberlite indicator mineral analysis. The diamonds, two yellow and one grey, were recovered from the plus-0.1-millimetre-to-minus-0.3-millimetre size fraction, and compositions were confirmed with a scanning electron microscope (SEM).

"The recovery of microdiamonds is extraordinary given that the primary objective of the laboratory process was to extract kimberlite indicator minerals, not diamonds," stated Bruce Counts, president and chief executive officer of Lithoquest. "This confirms that rocks present at target 0702 are diamond bearing and reinforces the prospective nature of the North Kimberley diamond project. We look forward to the commencement of the 2018 field program that will include drilling to collect samples specifically for microdiamond testing."

The sample that yielded the diamonds was collected in December, 2017, from a highly weathered outcrop of suspected kimberlite at target 0702. It was included in a group of six samples (two from anomaly 1605 and four from anomaly 0702) submitted for indicator mineral testing. No kimberlite indicator minerals or microdiamonds were recovered from the other five samples submitted.

The sample results reported in this release were obtained from Diamond Recovery Services Pty. Ltd., an independent laboratory located in Perth, Western Australia. The samples were transported from the field to the laboratory with security seals applied under dual custody and all seals were reported intact upon receipt at the laboratory. The laboratory employs a traditional recovery process involving heavy liquid separation and caustic fusion to liberate and recover kimberlite indicator minerals. Samples were initially crushed to minus 1.5 millimetres and a heavy mineral concentrate was produced from the minus-1.0-millimetre size fraction through heavy liquid separation. The minus-1.0-millimetre concentrate was sized using a 0.3-millimetre square mesh screen and the minus-0.3-millimetre size fraction was fused. The fusion residue from the fine fraction and the plus-0.3-millimetre-to-minus-1.0-millimetre size fraction from the concentrate were then observed for indicator minerals and diamonds. Grains that could not be positively identified during observation were submitted to the SEM at CSIRO's advanced characterization facility based at the Australian Resources and Research Centre in Perth, Australia.

Qualified person
The technical contents of this news release have been reviewed and approved by Bruce Counts, PGeo, president, chief executive officer and a director of Lithoquest Diamonds and qualified person under National Instrument 43-101.

About Lithoquest Diamonds Inc.
Lithoquest is a Canadian diamond exploration company focused on the discovery and development of economic diamond deposits on its 100-per-cent-owned North Kimberley diamond project located in Western Australia, approximately 65 kilometres east of the community of Kalumburu.
We seek Safe Harbor.

Aston Bay closes final tranche of financing for $2.25M

2018-04-02 08:22 ET - News Release

Mr. Thomas Ullrich reports
ASTON BAY HOLDINGS CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT
Aston Bay Holdings Ltd. closed the final tranche of the company's non-brokered private placement on March 29, 2018, raising gross proceeds of $2,252,081. The offering, which was announced on Dec. 12, 2017, was conducted in three tranches and raised aggregate gross proceeds of $4,466,991, an oversubscription of $466,991 over the originally announced target amount.

Pursuant to the third tranche of the offering, the company issued an additional 12,806,672 non-flow-through units at a price of 15 cents per unit, and an additional 2,069,250 flow-through shares at a price of 16 cents per FT share. Details of the first and second tranches were disclosed in the company's news releases of Dec. 29, 2017, and March 1, 2018, respectively. Each unit consists of one common share of the company and one-half of one warrant. Each full warrant will entitle the holder thereof to acquire an additional non-flow-through common share of the company at an exercise price of 20 cents per warrant for a period of 24 months from the date of issuance.

In connection with the third tranche of the offering, Aston Bay will pay aggregate cash finders' fees of $81,245.09 to 12 arm's-length finders, representing 6 per cent of the proceeds raised from subscriptions by certain placees introduced by the finders. The company is also issuing to the finders share purchase warrants entitling the purchase of an aggregate 534,820 common shares, representing 6 per cent of the number of units issued in connection with certain subscriptions, on the same terms as the warrants.

All shares acquired by the placees under the third tranche of the offering, and shares which may be acquired upon the exercise of the warrants and the finder's warrants, are subject to a hold period until July 30, 2018, in accordance with applicable Canadian securities legislation. Securities issued in connection with the first tranche of the offering are subject to a hold period until April 29, 2018, and securities issued in connection with the second tranche are subject to a hold period until July 2, 2018. Completion of the offering is subject to all required regulatory approvals, including final acceptance by the TSX Venture Exchange. Conditional acceptance of the offering was received from the exchange on Dec. 19, 2017, and on March 26, 2018. The company is awaiting final acceptance of the offering.

Proceeds of this offering will be used for a planned 2018 drill program on the Aston Bay property, for advancing the Storm copper and Seal zinc projects, and for general corporate purposes. Due to strong indications of institutional demand beyond the approval limits of the existing offering, the company has also applied to the exchange for conditional approval regarding an additional offering of up to $2-million in flow-through shares. Proceeds of this offering, should it be accepted and completed, would be used to expand existing plans for exploration activities at the Storm copper and Seal zinc projects during the 2018 summer exploration season, and in particular to finance a second drill rig and expand the amount of drilling during the 2018 campaign. There is no guarantee that the exchange will conditionally accept an additional offering by the company.

An insider of the company participated in the third tranche of the offering, having purchased 62,500 FT shares, constituting a related party transaction pursuant to TSX Venture Exchange Policy 5.9 and Multilateral Instrument 61-101 -- Protection of Minority Security Holders in Special Transactions. The company relied on Section 5.5(a) of MI 61-101 for an exemption from the formal valuation requirement and Section 5.7(1)(a) of MI 61-101 for an exemption from the minority shareholder approval requirement of MI 61-101 as the fair market value of the transaction insofar as the transaction involved interested parties did not exceed 25 per cent of the company's market capitalization.

About Aston Bay Holdings Ltd.
Aston Bay Holdings is a publicly traded mineral exploration company exploring for large, high-grade, sediment-hosted copper and zinc deposits in Nunavut, a mining-friendly Canadian jurisdiction. Aston Bay is 100-per-cent owner of the 1,024,345-acre (414,537 hectares) Aston Bay property located on western Somerset Island, Nunavut. The Aston Bay property hosts the Storm copper project and the Seal zinc deposit, with historical drilling confirming the presence of sediment-hosted copper and zinc mineralization.
We seek Safe Harbor.

Natcore plans Foil Cell demo with solar cell maker

2018-03-27 14:47 ET - News Release

Mr. Chuck Provini reports
NATCORE PLANNING PROTOTYPE DEMONSTRATION WITH MAJOR SOLAR CELL MANUFACTURER
Continuing its new focus on an accelerated prototype development program, a major global solar cell manufacturer has accepted Natcore Technology Inc.'s exclusive invitation to demonstrate its Natcore Foil Cell technology. The meeting and demonstration, to be held at Natcore's Rochester laboratory in advance of the World Conference on Photovoltaic Energy Conversion (June 10-15, 2018), is in keeping with the company's goal of pursuing partnerships with leaders in the industry to commercialize its technology. The production and demonstration of a prototype cell using a carrier selective contact process amenable to a streamlined, self-aligning production method will be a key part of this initiative.

Natcore will be participating in the WCPEC conference, which is held every four years and combines the three major international solar conferences that are otherwise held annually.
Natcore also announces that Dr. David Levy, Director of Research & Technology, is resigning his full-time position and has agreed to work with the Company on a consultant basis to advance its research, in particular the development of the demonstration prototype.

While Natcore pursues a full-time replacement for Dr. Levy, the Company is pleased to report that Dr. Dennis Flood, Chief Technology Officer, will direct the research and development program. Dr. Flood is a Natcore co-founder. He has more than 30 years experience in developing solar cell and array technology for both space and terrestrial applications. At the NASA Glenn Research Center in Cleveland, he served for 15 years as Chief of the Photovoltaic and Space Environments Branch and led programs in advanced photovoltaic systems development. He received two Agency awards for his pioneering work on advanced solar cells for space applications and for research that established the feasibility of powering a human outpost on the surface of Mars with solar energy. Dr. Flood presently serves on the International Advisory Committees of the European, the U.S, the Japan/Asia and the World Photovoltaic Conference organizing committees. He is an inventor or co-inventor on several patents or patent applications in photovoltaics and nanotechnology and has more than 100 peer-reviewed publications and presentations in solar energy, electron devices and materials science.

In addition to Dr. Flood, the Company's Science Advisory Board will continue to provide oversight and direction as the accelerated prototype development program advances toward completion.

About Natcore Technology
Natcore Technology is focused on using its proprietary Foil Cell technology to significantly lower the costs and improve the power output of solar cells.
We seek Safe Harbor.

John McAfee Joins CryptoSecure as Senior Strategic Advisor

Panama City, Panama -- March 14, 2018 -- ADVFN Crypto NewsWire -- CryptoSecure.com (through its Service Operator Crypto Investor, Inc.) is pleased to advise:

Appointment of John McAfee as Senior Strategic Advisor

John McAfee brings considerable expertise, both technical and industry specific to CryptoSecure. Mr. McAfee is a globally well-known brilliant, and controversial Internet and crypto pioneer and visionary. He spent his early years as a programmer for NASA’s Institute for Space Studies, and later created the world’s first commercial anti-virus software that still bears his name and is recognized as a leading global brand. Today he concentrates his passion and genius towards the future of cryptocurrency and blockchain technology. He is a champion of the people and a fierce advocate against the increasing incidence and nature of cyber-attacks.

Mr. McAfee met the CryptoSecure team on a recent Blockchain cruise conference at which he was the keynote speaker. During an early morning discussion on the security deficiencies of the cryptocurrency market, he was appraised of CryptoSecure’s military-grade hybrid Blockchain, Trusted Solaris OS, One Time Pad infrastructure project. When Mr. McAfee saw CryptoSecure’s first product ‘SafeWindow’ operating he immediately recognized the breakthrough potential to deliver the security so badly needed in the cryptoverse. Realizing that money could not buy this, he decided to join the CryptoSecure team as Senior Strategic Advisor.  

CryptoSecure ICO

Following collaboration with Mr. McAfee and his very committed and talented team over the past several weeks, and also with KickICO CryptoSecure’s ICO partner, CryptoSecure has re-focused and re-positioned its ICO and its marketing initiatives.

Participation in the ICO is only through exchange with Ethereum or KICK coins with exchange based upon a $975 fixed ETH pricing which is a significant premium to the current market.

Round One which closes in a week provides for SECURE coins to be exchanged for 0.0001026 ETH each, or 9750 SECURE coins per ETH. For details see:  https://CryptoSecure.com

About ‘SafeWindow’

The CryptoSecure Platforms first product, ‘SafeWindow’ is now released. ‘SafeWindow’ creates a virtual computer on the user computer screen, and also on the user’s tablet or smart device. These virtual existences are only there for the duration of the cryptocurrency activity or transaction. They cannot be seen by any hacker, authority, or spyware as the interaction is conducted in invisible virtuality. As soon as the activity or transaction is finished, the user closes the virtual windows, and everything vanishes leaving no residual trace of anything on any of the devices used. See how it works at Youtube-CryptoSecure.

“Very simply, if you cannot see it, then you cannot hack it, monitor, or record it”.

CryptoSecure Platform Development

Key Capital Corporation (OTC Pink: KCPC) is leading the full development of the CryptoSecure multilayer security Platform that will provide ultimate protection for crypto assets, private keys, communications, and privacy.
The CryptoSecure Platform incorporates a hybrid blockchain/Trusted Solaris OS/One Time Pad backbone within which ‘SafeWindow’ and other products and industry participants will be able to operate securely.

About KICKICO

KICKICO is an online blockchain technology-based platform for fundraising in cryptocurrencies. It collected more than 84,000 ETH during its ICO, and was named "ICO of the Year" by BTC CIS AWARDS. Today, KICKICO has a community of 55,000 people, and the KICK Coin is traded on eight exchanges. The platform has launched more than 20 projects, successfully completing their ICOs and raising more than 250,000 ETH in total funds, among them: Micromoney, Hacken, Universa, Playkey, INS. KICKICO also organized Cryptospace Moscow - one of the leading global blockchain and crypto events of 2017, gathering more than 3000 people and 59 top international blockchain and crypto experts.

To participate in the CryptoSecure ICO:
See Featured Campaigns at: https://www.kickico.com

For further information:
See: https://CryptoSecure.com

Email: info@cryptoinvestorinc.com
or
Darcy Johnston: darcy@cryptoinvestorinc.com
Chris Nichols: info@keycapitalgroup.com